This method demonstrates effective enrichment of DNA modifications in cultured cells, suggesting new diagnostic possibilities.
Efficient nucleic acid enrichment is pivotal for deciphering epigenetic modifications and disease biomarkers, yet current methods are constrained by insufficient specificity, poor versatility, and high costs. We developed a universal strategy named "Click-IP-Seq" by leveraging the high-affinity binding between Protein A/G and Fc region of DBCO-modified IgG. This enabled the directional conjugation of DBCO-IgG with any azide-modified nucleic acids via copper-free strain-promoted azide-alkyne cycloaddition (SPAAC) click chemistry, achieving specific capture and enrichment of modified nucleic acids. This method effectively enriches two major DNA modifications, 8-oxo-7,8-dihydroguanine (8-oxo-dG) and 5-hydroxymethylcytosine (5hmC), in model DNA systems. We successfully extended its application to map the genome-wide distribution of 8-oxo-dG in both cultured cells and human tissues. Furthermore, leveraging Click-IP-Seq, we conducted the first comprehensive profiling of 8-oxo-dG distribution and its associated biological functions in human colorectal carcinoma tissues. By repurposing IgG-Protein A/G interactions for DNA modification capture, this work circumvents the conventional reliance on biotin-streptavidin systems for DNA enrichment. Its cost-efficiency and modular design establish it as a viable alternative to biotin-streptavidin methods, offering utility for both fundamental epigenetic research and next-generation molecular diagnostics.
No takes yet. Share an insight, caveat, or question.
Zhai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: